NCT05275855View on ClinicalTrials.gov

First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

December 18, 2024

Study Completion Date

December 18, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

EDI048

Oral Liquid

OTHER

Placebo

Oral Liquid

Trial Locations (1)

NG11 6JS

Novartis Investigative Site, Mere Way

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY